PB
GSK icon

Pinnacle Bancorp’s GSK GSK Stock Holding History

Pinnacle Bancorp’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.2K Sell
1,759
-300
-15% -$15.9K 0.02% 364
2026
Q1 		$114K Sell
2,059
-589
-22% -$31.9K 0.03% 318
2025
Q4 		$130K Sell
2,648
-72
-3% -$3.36K 0.04% 290
2025
Q3 		$117K Buy
2,720
+1,888
+227% +$73.7K 0.03% 308
2025
Q2 		$31.9K Hold
832
– – 0.01% 507
2025
Q1 		$32.2K Sell
832
-224
-21% -$8.2K 0.01% 500
2024
Q4 		$35.7K Buy
1,056
+90
+9% +$3.24K 0.01% 480
2024
Q3 		$39.5K Hold
966
– – 0.01% 465
2024
Q2 		$37.2K Sell
966
-272
-22% -$11.4K 0.01% 449
2024
Q1 		$53.1K Buy
1,238
+211
+21% +$8.7K 0.02% 389
2023
Q4 		$38.1K Hold
1,027
– – 0.01% 434
2023
Q3 		$37.2K Sell
1,027
-272
-21% -$9.65K 0.01% 417
2023
Q2 		$46.3K Hold
1,299
– – 0.02% 384
2023
Q1 		$46.2K Hold
1,299
– – 0.02% 372
2022
Q4 		$46K Buy
+1,299
New +$43.3K 0.02% 349
2022
Q3 		– Sell
-1,223
Closed -$67K – 750
2022
Q2 		$67K Hold
1,223
– – 0.03% 283
2022
Q1 		$67K Buy
1,223
+21
+2% +$1.14K 0.02% 307
2021
Q4 		$66K Sell
1,202
-54
-4% -$2.81K 0.02% 312
2021
Q3 		$60K Hold
1,256
– – 0.02% 317
2021
Q2 		$63K Hold
1,256
– – 0.03% 310
2021
Q1 		$56K Buy
1,256
+487
+63% +$22.1K 0.03% 320
2020
Q4 		$35K Hold
769
– – 0.02% 380
2020
Q3 		$36K Sell
769
-964
-56% -$48.3K 0.03% 349
2020
Q2 		$88K Buy
1,733
+1,061
+158% +$54.4K 0.07% 217
2020
Q1 		$32K Hold
672
– – 0.03% 322
2019
Q4 		$39K Hold
672
– – 0.03% 343
2019
Q3 		$36K Sell
672
-480
-42% -$24.7K 0.02% 355
2019
Q2 		$58K Hold
1,152
– – 0.03% 275
2019
Q1 		$60K Buy
1,152
+80
+7% +$4K 0.03% 270
2018
Q4 		$51K Buy
+1,072
New +$52.8K 0.03% 282
2017
Q1 		$55K Buy
+1,036
New +$52.6K 0.04% 261

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Pinnacle Bancorp's GSK Position: Q2 2026 in Review

Pinnacle Bancorp reduced its GSK (GSK) stake by 15% in Q2 2026, selling an estimated $15.9K and leaving 1,759 shares worth $92.2K. The position accounts for 0.02% of the portfolio, ranked #364.

Pinnacle Bancorp first reported a position in GSK in Q1 2017 and has held it in 31 quarters since. The position peaked at $130K in Q4 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Pinnacle Bancorp held 1,759 shares of GSK worth $92.2K as of Q2 2026.
  • Pinnacle Bancorp sold 300 GSK shares in Q2 2026, an estimated $15.9K.
  • GSK made up 0.02% of Pinnacle Bancorp's portfolio in Q2 2026, its #364 holding.
  • Pinnacle Bancorp first reported a position in GSK in Q1 2017 and has held it in 31 quarters since.
  • Pinnacle Bancorp's GSK position peaked at $130K in Q4 2025.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.